Showing results (451-460 of 938) with videos related to
Sort By:
Pageof 94
Journal of Neurochemistry|July 19, 2000
No evidence for increased oxidative damage to lipids, proteins, or DNA in Huntington's diseaseZ I Alam, B Halliwell, P JennerAnnals of Neurology|September 28, 1998
Dopamine agonists and neuroprotection in Parkinson's diseaseC W Olanow, P Jenner, D BrooksJournal of Neurochemistry|October 1, 1982
Concentrations of GABA and other amino acids in CSF from torsion dystonia patientsT L Perry, S Hansen, N Quinn, et al.Archives of Neurology|September 1, 1989
Accuracy of self-reported disability in patients with parkinsonismR G Brown, B MacCarthy, M Jahanshahi, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|August 12, 1999
Neuronal nitric oxide synthase inhibition reduces MPP+-evoked hydroxyl radical formation but not dopamine efflux in rat striatumS Rose, J G Hindmarsh, P JennerThe European Journal of Neuroscience|January 3, 2001
The central aromatic amino acid DOPA decarboxylase inhibitor, NSD-1015, does not inhibit L-DOPA-induced circling in unilateral 6-OHDA-lesioned-ratsS A Treseder, S Rose, P JennerJournal of Neural Transmission (Vienna, Austria : 1996)|February 6, 2008
Striatal output markers do not alter in response to circling behaviour in 6-OHDA lesioned rats produced by acute or chronic administration of the monoamine uptake inhibitor BTS 74 398E L Lane, S Cheetham, P JennerThe Journal of Pharmacology and Experimental Therapeutics|November 16, 2004
Dopamine uptake inhibitor-induced rotation in 6-hydroxydopamine-lesioned rats involves both D1 and D2 receptors but is modulated through 5-hydroxytryptamine and noradrenaline receptorsE L Lane, S Cheetham, P JennerBritish Journal of Pharmacology|April 1, 2000
The effects of central aromatic amino acid DOPA decarboxylase inhibition on the motor actions of L-DOPA and dopamine agonists in MPTP-treated primatesS A Treseder, M Jackson, P JennerNeuroreport|July 31, 1995
Superoxide-dependent depletion of reduced glutathione by L-DOPA and dopamine. Relevance to Parkinson's diseaseJ P Spencer, P Jenner, B HalliwellPageof 94